DRUG Stock 12 Month Analyst Forecast
Eps Overview
Growth Next 5yrs
N/A
Last Quarter
- $0.54
Past Year
- $1.24
Growth Past 5yrs
-35.46%
Next Quarter
- $0.94
Estimate Next Year
-
Consensus Rating
Loading...
Consensus Price Target
Highest Price Target
$147.00
101.15% Upside
Mean Price Target
$102.00
39.57% Upside
Lowest Price Target
$72.00
-1.48% Downside
Recent Analyst Ratings
Upgrades, Downgrades, New Coverage
Actual EPS vs Estimated EPS
DRUG Earnings Per Share (EPS) History
According to financial reports, DRUG (NYSE: DRUG) reported an actual EPS of $-0.54323 for the quarter ending on Dec 23, 2025, compared to an estimated $-1.205, resulting in a -54.92% surprise. In the prior quarter (Aug 14, 2025), DRUG recorded an actual EPS of $-0.53 with a -10.17% surprise. See DRUG's full earnings history.
Earnings History
EPS Surprise Factor Analysis
DRUG has experienced notable EPS surprises, with the latest quarter ending Dec 23, 2025 showing a -54.92% miss. Previously, the quarter ending Aug 14, 2025 recorded a -10.17% miss. An EPS surprise factor indicates how much actual earnings deviate from analyst forecasts.
| Report Date | Actual | Forecast | Surprise Factor |
|---|---|---|---|
| Dec 23, 2025 | -0.54323 | -1.205 | -54.92% |
| Aug 14, 2025 | -0.53 | -0.59 | -10.17% |
| May 15, 2025 | -0.29 | -0.39 | -25.64% |
| Feb 13, 2025 | 0.01 | -0.23 | -104.35% |
| Dec 30, 2024 | -0.12 | -0.44343 | -72.94% |
Frequently Asked Questions
Is DRUG stock getting favorable reviews from Wall Street analysts?
Brokerage firms have given DRUG stock an average recommendation of
Buy. 8 analysts have given their ratings
to DRUG out of which
0 analysts have given strong buy call,
8 analysts have given buy call,
0 analysts rate it hold,
0 analysts advocate strong sell call, and
0 analysts has given sell rating. The average target price of
$102.00 gives the stock implied upside
of roughly 39.57% over the next year or so.
What have analysts suggested for DRUG highest price target?
Analysts suggest DRUG's stock price would rise to a high of $147.00.
What is the lowest price target analysts expect for DRUG over the next year?
Within the next 12 months, analysts predict the DRUG stock price could move to $72.00.
What is the average target price for DRUG?
DRUG stock has an average analyst estimate of $102.00.
At its current price, how far is DRUG from its average target price?
DRUG shares are currently trading 39.57% above this price target.
What were DRUG’s actual earnings per share for the recent quarter?
Its quarterly earnings per share (EPS) came in at - $0.54 versus consensus estimates of - $1.21, and below the comparable year-ago quarter’s EPS of - $0.12.
What are the current estimates for quarterly and annual earnings per share?
DRUG's forecasts by analysts estimating quarterly EPS at - $0.94 and - for the whole year.
What has DRUG's growth been in the past five years and what is expected in the next five years?
The analysts have projected N/A EPS growth for DRUG in the next five years, compared to growth rates of -35.46% in the past five years.